BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36343971)

  • 1. Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.
    McEachron J; Chen YJ; Zhou N; Kao J; Gorelick C; Kanis MJ; Lee YC
    Int J Gynecol Cancer; 2022 Nov; 32(11):1402-1409. PubMed ID: 36343971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
    McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
    Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
    Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.
    Gunther JR; Christensen EN; Allen PK; Ramondetta LM; Jhingran A; Fleming ND; Euscher ED; Lu KH; Eifel PJ; Klopp AH
    Int J Gynecol Cancer; 2018 Jan; 28(1):114-121. PubMed ID: 28930812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
    Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
    Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
    Garg G; Yee C; Schwartz K; Mutch DG; Morris RT; Powell MA
    Gynecol Oncol; 2014 May; 133(2):242-9. PubMed ID: 24561247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy.
    Seagle BL; Kanis M; Kocherginsky M; Strauss JB; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):71-77. PubMed ID: 28317560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML
    Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases.
    McEachron J; Marshall L; Zhou N; Tran V; Kanis MJ; Gorelick C; Lee YC
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.
    Patel N; Hegarty SE; Cantrell LA; Mishra MV; Showalter TN
    Brachytherapy; 2015; 14(5):606-12. PubMed ID: 26166579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes.
    Yilmaz U; Alanyali S; Aras AB; Ozsaran Z
    J Cancer Res Ther; 2019; 15(6):1377-1382. PubMed ID: 31898676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
    Cantrell LA; Havrilesky L; Moore DT; O'Malley D; Liotta M; Secord AA; Nagel CI; Cohn DE; Fader AN; Wallace AH; Rose P; Gehrig PA
    Gynecol Oncol; 2012 Oct; 127(1):22-6. PubMed ID: 22727985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus.
    Brown LC; Petersen IA; Haddock MG; Bakkum-Gamez JN; Lee LJ; Cimbak NC; Berkowitz RS; Viswanathan AN
    Brachytherapy; 2015; 14(4):433-9. PubMed ID: 25890795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.